Cure of Helicobacter pylori Infection after Failed Primary Treatment: One-Center Results from 120 Patients

References

• Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988;2:1437–42.
   PubMed Web of Science ®Google Scholar
• Rauws EA, Tytgat GN. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990;335:1233–5.
   PubMed Web of Science ®Google Scholar
• Graham DY, Lew GM, Klein PD, Evans DG, Evans DJ Jr, Saeed ZA, et al. Effect of treatment of Helicobacter pylori infection on the long term recurrence of gastric and duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992;116:705–8.
   PubMed Web of Science ®Google Scholar
• Hosking SW, Ling TK, Chung SC, Yung MY, Cheng AF, Sung JJ, et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment; randomised controlled trial. Lancet 1994;343:508–10.
   PubMed Web of Science ®Google Scholar
• Seppälä K, Pikkarainen P, Sipponen P, Kivilaakso E, Gormsen MH. Cure of peptic gastric ulcer associated with eradication of Helicobacter pylori. Finnish Gastric Ulcer Study Group. Gut 1995;36: 834–7.
   PubMed Web of Science ®Google Scholar
• De Boer W, Driessen W, Jansz A, Tytgat G. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995;345:817–20.
   PubMed Web of Science ®Google Scholar
• Borody TJ, Andrews P, Fracchia G, Brandl S, Shortis NP, Bae H. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut 1995;37:477–81.
   PubMed Web of Science ®Google Scholar
• Hosking SW, Ling TK, Yung MY, Cheng A, Chung SC, Leung TW, et al. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. Br Med J 1992;305:502–4.
   PubMed Web of Science ®Google Scholar
• Bell GD, Powell KU, Burridge SM, Bowden AF, Atoyebi W, Bolton GH, et al. Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 1995;9:41–6.
   PubMed Web of Science ®Google Scholar
• De Boer WA, Driessen WM, Potters VP, Tytgat GN. Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori. Am J Gastroenterol 1994;89:1993–7.
   PubMed Web of Science ®Google Scholar
• Walsh JH, Peterson WL. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med 1995;333:984–91.
   PubMed Web of Science ®Google Scholar
• Lind T, Veldhuyzen van Zanten S, Unge P, Spiller R, Bayerdorffer E, O’Morain C, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter 1996;1: 138–44.
   Google Scholar
• Unge P. Eradication therapy of Helicobacter pylori. A review. J Gastroenterol 1998;33 Suppl X:57–61.
   Google Scholar
• Marshall BJ. Treatment of Helicobacter pylori. In: Marshall BJ, McCallum RW, Guerrant RL, editors. Helicobacter pylori in peptic ulceration and gastritis. Boston: Blackwell Scientific Publications; 1991. p. 160–86.
   Google Scholar
• Borody TJ, Brandl S, Andrews P, Jankiewicz E, Ostapowicz N. H. pylori eradication failure (EF)—further treatment possibilities. Gastroenterology 1992;102:A43.
   Google Scholar
• Seppälä K, Sipponen P, Nuutinen H, Anisimova S, Kosunen TU. Intent to treat metronidazole resistant H. pylori infection to 100% of cure. Therapy with quadruple therapy and its modification. Gastroenterology 1995;108:A216.
   Google Scholar
• Van der Hulst RW, Weel JF, van der Ende A, ten Kate FJ, Dankert J, Tytgat GN. Therapeutic options after failed Helicobacter pylori eradication therapy. Am J Gastroenterol 1996;91:2333–7.
   PubMed Web of Science ®Google Scholar
• Borody TJ, Shortis NP, Chongnan J, Reyes E, O’Shea JE. Eradication failure (EF) after H. pylori treatment—further therapies. Gastroenterology 1996;110:A67.
   Google Scholar
• Lerang F, Moum B, Haug JB, Berge T, Tolas P, Sandvei PK, et al. Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy. Scand J Gastroenterol 1997;32:1209–14.
   PubMed Web of Science ®Google Scholar
• Van der Hulst RW, van’t Hoff BWM. Treatment of Helicobacter pylori eradication failure. Gastroenterol Int 1997;10:153–60.
   Google Scholar
• Borody TJ, Shortis NP, Reyes E. Eradication therapies for Helicobacter pylori. J Gastroenterol 1998;33 Suppl X:53–6.
   Google Scholar
• Rautelin H, Seppälä K, Renkonen OV, Vainio U, Kosunen TU. Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother 1992;36:163–6.
   PubMed Web of Science ®Google Scholar
• Seppälä K, Färkkilä M, Nuutinen H, Hakala K, Väänänen H, Rautelin H, et al. Triple therapy of Helicobacter pylori infection in peptic ulcer. A 12-month follow-up study of 93 patients. Scand J Gastroenterol 1992;27:973–6.
   PubMed Web of Science ®Google Scholar
• Kosunen TU, Seppälä K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992;339:893–5.
   PubMed Web of Science ®Google Scholar
• Brown RA, Beck JS. Statistics on microcomputers. A non-algebraic guide to the appropriate use of statistics packages in biomedical research and pathology laboratory practice. 5. Analysis of categorical data. J Clin Pathol 1989;42:117–22.
   Google Scholar
• Bayerdörffer E, Mannes GA, Sommer A, Höchter W, Weingart J, Hat Z, et al. High dose omeprazole treatment combined with amoxicillin eradicates Helicobacter pylori. Eur J Gastroenterol Hepatol 1992;4:697–702.
   Google Scholar
• Reddy R, Osato M, Gutierrez O, Kim JG, Graham DY. Metronidazole resistance is high in Korea and Colombia and appears to be rapidly increasing in the U.S. Gastroenterology 1996;110 Suppl 4:A238.
   Google Scholar
• Banatvala N, Davies GR, Abdi Y, Clements L, Rampton DS, Hardie JM, et al. High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut 1994;35:1562–6.
   PubMed Web of Science ®Google Scholar
• Ching CK, Leung KP, Yung RW, Lam SK, Wong BC, Lai KC, et al. Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong. Gut 1996;38:675–8.
   PubMed Web of Science ®Google Scholar
• Lerang F, Moum B, Ragnhildstveit E, Sandvei PK, Tolas P, Whilst JE, et al. Simplified 10-day bismuth triple therapy for cure of Helicobacter pylori infection: experience from clinical practice in a population with high frequency of metronidazole resistance. Am J Gastroenterol 1998;93:212–6.
   PubMed Web of Science ®Google Scholar
• Moshkowitz M, Konikoff FM, Peled Y, Brill S, Hallak A, Tiomny E, et al. One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients. Aliment Pharmacol Ther 1996;10:1015–9.
   PubMed Web of Science ®Google Scholar
• Bell GD, Powell KU. Helicobacter pylori reinfection after apparent eradication—the Ipswich experience. Scand J Gastroenterol 1996;31 Suppl 215:96–104.
   Web of Science ®Google Scholar
• Cayla R, Zerbib F, Talbi P, Mégrand F, Lamouliane H. Pre and post-treatment clarithromycin resistance of Helicobacter pylori strains: a key factor of treatment failure. Gut 1995;37 Suppl 1:A55.
   Google Scholar
• Xia HX, Buckley M, Hyde D, Keane CT, O’Morain CA. Effects of antibiotic resistance on clarithromycin-combined triple therapy for Helicobacter pylori. Gut 1995;37 Suppl 1:A55.
   Web of Science ®Google Scholar
• Buckley MJ, Xia HX, Hyde DM, Keane CT, O’Morain CA. Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance. Dig Dis Sci 1997;42:2111–5.
   Google Scholar
• Färkkilä M, Julkunen R, Niemelä S, Nuutinen H, Kosunen T, Karvonen A-L, et al. Suositus Helicobacter pylori-infektion diagnostiikasta, hoidosta ja seurannasta. Suom Lääkl 1996;51: 9–13.
   Google Scholar
• Rauws EJ. Reasons for failure of Helicobacter pylori treatment. Eur J Gastroenterol Hepatol 993;5 Suppl 2:S92–5.
   Google Scholar
• Graham DY, De Boer WA, Tytgat GN. Choosing the best antiHelicobacter pylori therapy: effect of antimicrobial resistance. Am J Gastroenterol 1996;91:1072–6.
   PubMed Web of Science ®Google Scholar
• Rauws EA, van der Hulst RW. The management of H. pylori infection. Br Med J 1998;316:162–3.
   PubMed Web of Science ®Google Scholar
• Deltenre M, Ntounda R, Jonas C, De Koster E. Eradication of Helicobacter pylori: why does it fail? Ital J Gastroenterol Hepatol 1998;30 Suppl 3:S326–8.
   PubMed Web of Science ®Google Scholar